Skip to main content
. 2018 Oct 25;20(3):307–320. doi: 10.1080/15384047.2018.1529098

Figure 1.

Figure 1.

Expression of STK32C in bladder cancer and other cancers from TCGA. (a) Gene expression matrix of 414 of bladder cancer was downloaded from the TCGA database. Expression of the STK32C gene in overall bladder tumor samples was higher than normal controls. (P < 0.001) (b) 19 patients had tumors and adjacent normal control samples. Expression of the STK32C gene in 19 paired samples changed significantly. (P < 0.001) (c-d) Of 19 of paired samples, 12 samples were up-regulated, 1 was down-regulated, and 6 did not change insignificantly. (e)The mutation, amplification, deep deletion and mRNA upregulation of the STK32C gene in BC patients from TCGA. (f) Expression of STK32C was over-expressed in BRCA, ESCA, HNSC, STAC and PRAD, down-expressed in LUSC, and non-significant in LIHC and LUAD.